+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
ID05255653

RAINBO MMRd-GREEN Trial Comparing Adjuvant Radiotherapy With or Without Durvalumab in Endometrial Cancer Based on Molecular Features

Led by Leiden University Medical Center · Updated on 2026-10-08

316

Participants Needed

60

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

The trial investigates adjuvant treatment options for women with endometrial cancer characterized by mismatch repair deficiency MMRd. It is a phase III international, multicenter, randomized study comparing pelvic external beam radiotherapy combined with and followed by durvalumab for one year to pelvic external beam radiotherapy with or without chemotherapy. This trial is part of the larger RAINBO research project which aims to refine adjuvant treatment based on molecular features of endometrial cancer. Participants receive either pelvic external beam radiotherapy alone or combined with chemotherapy according to the PORTEC-3 schedule, or pelvic external beam radiotherapy plus durvalumab given intravenously every 4 weeks for 13 cycles one year. Vaginal brachytherapy may be considered for certain patients with specific tumor involvement. The trial includes detailed radiation dosing and chemotherapy regimens, with durvalumab starting within the first week of radiotherapy. Participants will be monitored for recurrence-free survival over three years, along with efficacy, quality of life, safety, and biomarker outcomes for up to five years. Assessments include clinical evaluations, imaging, laboratory tests, and translational research on tumor material. The study requires follow-up and treatment accessibility, with informed consent and permissions for research use of tissue and data. The total duration includes treatment and long-term follow-up to evaluate treatment impact and safety.

CONDITIONS

Brief Title

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

Research Team

E

Elma Meershoek- Klein Kranenbarg

A

Annet Roodvoets

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here